What is the recommended diagnostic algorithm for HIV infection, including pre‑test counseling, screening with a fourth‑generation HIV‑1/2 antibody/antigen assay, confirmatory differentiation immunoassay or HIV‑1 RNA testing, and post‑test counseling?

HIV Diagnosis: Recommended Diagnostic Algorithm

Begin HIV screening with a fourth-generation HIV-1/2 antigen/antibody combination assay, followed by an HIV-1/HIV-2 antibody differentiation immunoassay if reactive, and then HIV-1 RNA testing if results remain discordant or indeterminate. 1, 2

Pre-Test Counseling and Consent

Implement opt-out screening: Inform patients orally or in writing that HIV testing will be performed unless they explicitly decline, incorporating consent into general medical care consent rather than requiring separate written HIV consent. 3, 2

• Provide easily understood informational materials in the patient's preferred language 3
• Document patient refusal in the medical record if testing is declined 3
• Critical caveat: Some states still require written informed consent—verify local regulations before implementing opt-out screening 3

Step 1: Initial Screening Test

Use a fourth-generation HIV-1/2 antigen/antibody combination assay as the primary screening test, which detects both p24 antigen and HIV antibodies, identifying acute infection approximately 2 weeks earlier than antibody-only tests. 1, 2, 4

• Fourth-generation assays reduce the window period to 11-14 days post-infection 5
• If fourth-generation testing is unavailable, use a rapid HIV test or conventional ELISA, though these are less sensitive for acute infection 1, 2
• Rapid tests can be performed on whole blood, plasma, serum, or oral fluid, but oral fluid specimens have higher false-positive rates 1, 2

If the initial screening test is non-reactive: Report as HIV-negative. 2, 4

If the initial screening test is reactive: Perform repeat testing in duplicate immediately; if repeatedly reactive, proceed to Step 2. 3, 2

Step 2: Confirmatory Differentiation Testing

Perform an HIV-1/HIV-2 antibody differentiation immunoassay on all specimens with repeatedly reactive screening results. 1, 2, 4

• If differentiation assay is positive for HIV-1 or HIV-2: Confirm HIV infection and report accordingly 2, 4
• If differentiation assay is negative or indeterminate: Immediately proceed to Step 3 2, 6, 4

Traditional Algorithm (Still Valid)

The older Western blot (WB) or immunofluorescence assay (IFA) approach remains acceptable when newer assays are unavailable:

• A positive Western blot confirms HIV infection with sensitivity and specificity ≥99% 2, 6
• An indeterminate Western blot requires repeat testing in 4-6 weeks and consideration of HIV-RNA testing 6, 7
• A negative Western blot indicates the person is uninfected unless acute infection is suspected 6

Step 3: HIV-1 RNA Nucleic Acid Testing

Perform qualitative or quantitative HIV-1 RNA testing (nucleic acid amplification test) when the differentiation assay is negative or indeterminate despite a reactive screening test. 1, 2, 4

• If HIV-1 RNA is positive: Confirms acute HIV-1 infection even when antibody results are negative 1, 2, 4
• If HIV-1 RNA is negative: The individual is considered uninfected; the reactive screening result was a false positive 2, 4

Special Scenario: Suspected Acute HIV Infection

When acute retroviral syndrome is clinically suspected (fever, malaise, lymphadenopathy, skin rash, recent high-risk exposure), order HIV-1 RNA testing immediately, even if antibody tests are negative. 3, 1, 2

• Acute retroviral syndrome occurs in the first few weeks after infection, before antibody seroconversion 3
• Antibody tests cannot exclude infection that occurred less than 6 months before testing; ≥95% of patients develop detectable antibodies within 6 months 3, 2
• Critical for morbidity/mortality: Early detection and immediate antiretroviral therapy during acute infection can delay HIV-related complications and improve long-term prognosis 3

Special Populations

Infants <18 Months Born to HIV-Positive Mothers

Do not use standard antibody tests for diagnosis, as maternal HIV antibodies cross the placenta and persist up to 15-18 months. 3, 2, 6

• Definitive diagnosis requires two positive HIV-RNA PCR or viral culture tests on separate specimens 2, 6
• Perform HIV-RNA testing at ≤1 month of age and again at ≤4 months of age 2

HIV-2 Testing Considerations

Test for HIV-2 in specific populations: persons from endemic regions (West Africa, Angola, Mozambique, Portugal, France) or their sexual partners. 3, 2, 6

• Also test for HIV-2 when clinical signs of HIV disease are present but HIV-1 antibody tests are negative 3, 2
• HIV-2 prevalence in the United States is extremely low; routine testing is not recommended outside these specific scenarios 3

Patients Using Pre-Exposure Prophylaxis (PrEP)

PrEP use can attenuate or delay seroconversion, leading to reactive results that may represent true infection or false positives. 2, 6

• If pre-test probability is low: Discontinue PrEP for 3-4 weeks and repeat testing 2, 6
• If pre-test probability is high: Initiate full antiretroviral therapy immediately 2, 6

Post-Test Counseling and Immediate Actions

For Confirmed HIV-Positive Results

All patients with confirmed HIV infection must receive immediate medical and psychosocial evaluation or referral. 3, 2, 6

Obtain comprehensive baseline testing before initiating therapy:

• HIV RNA viral load level 1, 6
• CD4 cell count with percentage 1, 6
• HIV genotype resistance testing 1
• Hepatitis B and C screening 1
• Sexually transmitted infection screening 1
• Tuberculosis screening 1
• Baseline renal function (creatinine clearance) 1
• Baseline liver function tests 1

Initiate antiretroviral therapy immediately upon diagnosis, regardless of CD4 count or viral load—this is critical for reducing morbidity and mortality. 1, 6

Provide behavioral and psychosocial services as an integral component of HIV care, addressing adaptive challenges including coping with stigma, maintaining physical/emotional health, and preventing transmission to others. 3, 1, 6

For Negative Results

Provide HIV test results in the same manner as other diagnostic tests. 3

• Prevention counseling is strongly encouraged for persons at high risk but should not be required as part of routine screening 3
• Persons at high risk for HIV should be screened at least annually 3

Common Pitfalls to Avoid

Never diagnose HIV based on a screening test alone—all reactive screening tests must be confirmed before diagnosis, as false-positive results can have devastating psychological and social consequences. 2, 6

Do not delay treatment while awaiting resistance testing results—immediate antiretroviral therapy initiation improves outcomes. 1

Recognize the window period: False-negative results can occur during recent infection within the first 2-6 weeks, even with fourth-generation assays. 3, 2, 5

For indeterminate results: Always follow up with repeat testing at 4-6 weeks and consider HIV-RNA testing rather than leaving patients in diagnostic limbo. 6, 7

Document opt-out decisions: When patients decline testing, this must be recorded in the medical record to ensure proper follow-up. 3